2.43
price down icon0.82%   -0.02
after-market Dopo l'orario di chiusura: 2.38 -0.05 -2.06%
loading

Spero Therapeutics Inc Borsa (SPRO) Ultime notizie

pulisher
Mar 31, 2026

SPRO Forecast, Price Target & Analyst Ratings | SPERO THERAPEUTICS INC (NASDAQ:SPRO) - ChartMill

Mar 31, 2026
pulisher
Mar 29, 2026

Spero Therapeutics (NASDAQ:SPRO) Upgraded by Wall Street Zen to "Strong-Buy" Rating - marketbeat.com

Mar 29, 2026
pulisher
Mar 28, 2026

Spero Therapeutics (NASDAQ:SPRO) versus Mereo BioPharma Group (NASDAQ:MREO) Financial Contrast - Defense World

Mar 28, 2026
pulisher
Mar 27, 2026

Best Momentum Stock to Buy for October 10th - MSN

Mar 27, 2026
pulisher
Mar 27, 2026

Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives - Sahm

Mar 27, 2026
pulisher
Mar 26, 2026

Spero Therapeutics shares jump over 4% on better-than-expected Q4 print - Investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update - Bitget

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics earnings beat by $0.73, revenue topped estimates - Investing.com Canada

Mar 26, 2026
pulisher
Mar 26, 2026

SPERO THERAPEUTICS ($SPRO) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics (NASDAQ:SPRO) Posts Earnings Results, Beats Estimates By $0.73 EPS - MarketBeat

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics Q4 revenue nearly triples, swings to profit - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics 2025 10-K: $66.8M Revenue, $0.15 EPS - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Spero Therapeutics (NASDAQ: SPRO) turns 2025 profit as tebipenem advances - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

[10-K] Spero Therapeutics, Inc. Files Annual Report - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Can Spero Therapeutics Inc sustain earnings growth2026 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 24, 2026

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround - MSN

Mar 24, 2026
pulisher
Mar 23, 2026

Analyst Calls: Is Spero Therapeutics Inc stock showing strong momentumWeekly Gains Summary & Fast Moving Stock Watchlists - baoquankhu1.vn

Mar 23, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Spero Therapeuti (SPRO) - Stock Titan

Mar 22, 2026
pulisher
Mar 21, 2026

Spero Therapeutics (NASDAQ:SPRO) Downgraded by Wall Street Zen to "Hold" - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

Spero Therapeutics (SPRO.US) will release its earnings report after the market closes on March 26. - 富途牛牛

Mar 21, 2026
pulisher
Mar 20, 2026

SPRO Stock Price, Quote & Chart | SPERO THERAPEUTICS INC (NASDAQ:SPRO) - ChartMill

Mar 20, 2026
pulisher
Mar 19, 2026

Activity Recap: Is Spero Therapeutics Inc stock showing strong momentumPortfolio Gains Summary & Fast Gain Stock Tips - baoquankhu1.vn

Mar 19, 2026
pulisher
Mar 19, 2026

Spero Therapeutics (SPRO) Expected to Announce Earnings on Thursday - marketbeat.com

Mar 19, 2026
pulisher
Mar 18, 2026

Spero Therapeutics Inc 預計每股虧損 55 美分財報前瞻 - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026 - MarketScreener

Mar 18, 2026
pulisher
Mar 18, 2026

Spero Therapeutics to Report Fourth Quarter and Full Year - GlobeNewswire

Mar 18, 2026
pulisher
Mar 16, 2026

Weekly Earnings: What are Spero Therapeutics Incs recent SEC filings showingQuarterly Trade Report & Capital Efficient Trading Techniques - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Large Decline in Short Interest - MarketBeat

Mar 15, 2026
pulisher
Mar 12, 2026

Profit Recap: Is Spero Therapeutics Inc stock showing strong momentumStop Loss & Weekly High Conviction Trade Ideas - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Spero Therapeutics Inc erwartet einen Verlust von 55 Cents pro AktieEarnings Preview - TradingView

Mar 12, 2026
pulisher
Mar 10, 2026

Spero Therapeutics (NASDAQ:SPRO) Stock Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat

Mar 10, 2026
pulisher
Mar 07, 2026

Dow Update: Can Spero Therapeutics Inc lead its sector in growth2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Stock Recap: Can Spero Therapeutics Inc ride the EV waveMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Big Picture: Will Spero Therapeutics Inc benefit from seasonalityWeekly Profit Summary & Weekly Market Pulse Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

SPRO SEC FilingsSpero Therapeuti 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 02, 2026

Short Interest in Spero Therapeutics, Inc. (NASDAQ:SPRO) Declines By 24.0% - MarketBeat

Mar 02, 2026
pulisher
Feb 27, 2026

SPRO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 27, 2026
pulisher
Feb 25, 2026

Spero Therapeutics (NASDAQ:SPRO) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat

Feb 25, 2026
pulisher
Feb 21, 2026

Can Spero Therapeutics Inc. (2HA) stock sustain margin levels2025 Trading Recap & Fast Entry Momentum Trade Alerts - mfd.ru

Feb 21, 2026
pulisher
Feb 16, 2026

Aug PostEarnings: Can Spero Therapeutics Inc sustain earnings growth2025 Retail Activity & Low Drawdown Trading Strategies - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 14, 2026

Valuation Update: Is Spero Therapeutics Inc stock showing strong momentum2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 14, 2026

Trade Alert: CEO, CFO Of Spero Therapeutics Esther Rajavelu Has Sold Stock - simplywall.st

Feb 14, 2026
pulisher
Feb 13, 2026

Is Spero Therapeutics Inc. a good stock for dollar cost averaging2025 Price Targets & Weekly High Potential Stock Alerts - mfd.ru

Feb 13, 2026
pulisher
Feb 11, 2026

Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO) - Seeking Alpha

Feb 11, 2026
pulisher
Feb 09, 2026

Esther Rajavelu Sells 87,917 Shares of Spero Therapeutics (NASDAQ:SPRO) Stock - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Keutzer, Spero Therapeutics COO, sells $44k in shares - Investing.com

Feb 09, 2026
pulisher
Feb 09, 2026

Spero Therapeutics CEO sells $207k in stock By Investing.com - Investing.com Canada

Feb 09, 2026
pulisher
Feb 09, 2026

Keutzer, Spero Therapeutics COO, sells $44k in shares By Investing.com - Investing.com Canada

Feb 09, 2026
pulisher
Feb 09, 2026

Spero Therapeutics CEO sells $207k in stock - Investing.com

Feb 09, 2026
pulisher
Feb 06, 2026

Aug Breakouts: What drives Spero Therapeutics Incs stock priceEarnings Summary Report & Safe Entry Zone Tips - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 05, 2026

Spero Therapeutics (NASDAQ:SPRO) Insider Sells 18,442 Shares - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Spero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

Spero therapeutics exec Rajavelu sells $40k in shares By Investing.com - Investing.com Australia

Feb 04, 2026
pulisher
Feb 04, 2026

Spero therapeutics exec Rajavelu sells $40k in shares - Investing.com

Feb 04, 2026
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):